FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutical industry and represents a pharmaceutical composition for reducing triglycerides in an individual in need thereof, wherein the pharmaceutical composition contains at least 95 wt % of EPA of total fatty acids present in the composition and HMG-CoA reductase inhibitor.
EFFECT: invention provides reducing triglycerides in the individual in need thereof.
28 cl, 1 ex, 4 dwg
Authors
Dates
2013-08-10—Published
2010-04-29—Filed